Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 20

Results For "IMI"

5040 News Found

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026
Supply Chain | May 08, 2026

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026

The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore


Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform
News | May 07, 2026

Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform

LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity


Safic-Alcan expands in India with majority stake in SA Ingredients
News | May 07, 2026

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint


Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Drug Approval | May 07, 2026

Venus Remedies gets marketing authorization for Ceftriaxone in Argentina

Approval strengthens the company’s growing international anti-infective portfolio


GIMS Greater Noida expands paediatric orthopaedic care under Healthium's CSR initiative
Hospitals | May 07, 2026

GIMS Greater Noida expands paediatric orthopaedic care under Healthium's CSR initiative

Supported by Plan International, the partnership will help treat over 1,000 children annually


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


Neurobion introduces nerve pain relief cream
Healthcare | May 07, 2026

Neurobion introduces nerve pain relief cream

The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil


Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility
Biopharma | May 06, 2026

Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility

The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026


Laurus Labs Q4 profit rises to Rs. 279 crore, FY26 revenue up 23%
News | May 06, 2026

Laurus Labs Q4 profit rises to Rs. 279 crore, FY26 revenue up 23%

The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms